[Transfusion safety]

Same author

Inventory management.

Vox sanguinis·2010

Same author

Prevention and diagnosis of delayed haemolytic transfusion reactions.

Vox sanguinis·2006

Same author

Preoperative autologous blood donation in primary total knee arthroplasty: a single-centre experience on 214 consecutive patients.

Vox sanguinis·2006

Same author

Nucleic acid amplification technology screening for HBV DNA in Italy: routine application. Report on the first HBV DNA-positive HBsAG-negative donor.

Transfusion medicine (Oxford, England)·2005

Same author

[Transfusional therapy of hemodialyzed patient with anti-Cartwright antibodies: case report and review of the literature].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2004

Same author

Non-ABO red blood cell alloantibodies following allogeneic hematopoietic stem cell transplantation.

Bone marrow transplantation·2004

Same journal

Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myeloma.

Haematologica·2026

Same journal

Incidence and predictors of recurrent venous thromboembolism after isolated distal deep vein thrombosis: a <i>post-hoc</i> analysis of the RIDTS trial.

Haematologica·2026

Same journal

Philadelphia positive T-acute lymphoblastic leukemia: a Mayo Clinic series.

Haematologica·2026

Same journal

Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia.

Haematologica·2026

Same journal

Reframing leukemia-niche interactions: the emerging role of the marrow adipocyte lineage.

Haematologica·2026

Same journal

A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma.

Haematologica·2026

Related Experiment Videos

[Transfusion safety]

Related Concept Videos

Inventory management.

Prevention and diagnosis of delayed haemolytic transfusion reactions.

Preoperative autologous blood donation in primary total knee arthroplasty: a single-centre experience on 214 consecutive patients.

Nucleic acid amplification technology screening for HBV DNA in Italy: routine application. Report on the first HBV DNA-positive HBsAG-negative donor.

[Transfusional therapy of hemodialyzed patient with anti-Cartwright antibodies: case report and review of the literature].

Non-ABO red blood cell alloantibodies following allogeneic hematopoietic stem cell transplantation.

Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myeloma.

Incidence and predictors of recurrent venous thromboembolism after isolated distal deep vein thrombosis: a <i>post-hoc</i> analysis of the RIDTS trial.

Philadelphia positive T-acute lymphoblastic leukemia: a Mayo Clinic series.

Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia.

Reframing leukemia-niche interactions: the emerging role of the marrow adipocyte lineage.

A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma.

Related Experiment Videos

[Transfusion safety]

Related Concept Videos

Related Articles

Inventory management.

Prevention and diagnosis of delayed haemolytic transfusion reactions.

Preoperative autologous blood donation in primary total knee arthroplasty: a single-centre experience on 214 consecutive patients.

Nucleic acid amplification technology screening for HBV DNA in Italy: routine application. Report on the first HBV DNA-positive HBsAG-negative donor.

[Transfusional therapy of hemodialyzed patient with anti-Cartwright antibodies: case report and review of the literature].

Non-ABO red blood cell alloantibodies following allogeneic hematopoietic stem cell transplantation.

Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myeloma.

Incidence and predictors of recurrent venous thromboembolism after isolated distal deep vein thrombosis: a <i>post-hoc</i> analysis of the RIDTS trial.

Philadelphia positive T-acute lymphoblastic leukemia: a Mayo Clinic series.

Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia.

Reframing leukemia-niche interactions: the emerging role of the marrow adipocyte lineage.

A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma.